500 related articles for article (PubMed ID: 25172118)
1. Development of (18)F-labeled radiotracers for neuroreceptor imaging with positron emission tomography.
Brust P; van den Hoff J; Steinbach J
Neurosci Bull; 2014 Oct; 30(5):777-811. PubMed ID: 25172118
[TBL] [Abstract][Full Text] [Related]
2. Pyrazoles as Key Scaffolds for the Development of Fluorine-18-Labeled Radiotracers for Positron Emission Tomography (PET).
Gomes PMO; Silva AMS; Silva VLM
Molecules; 2020 Apr; 25(7):. PubMed ID: 32283680
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Impact of structural alterations on the radiopharmacological profile of
Tietz O; Marshall A; Bergman C; Wuest M; Wuest F
Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798
[TBL] [Abstract][Full Text] [Related]
5. Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging.
Sadeghzadeh M; Wenzel B; Gündel D; Deuther-Conrad W; Toussaint M; Moldovan RP; Fischer S; Ludwig FA; Teodoro R; Jonnalagadda S; Jonnalagadda SK; Schüürmann G; Mereddy VR; Drewes LR; Brust P
Molecules; 2020 May; 25(10):. PubMed ID: 32423056
[TBL] [Abstract][Full Text] [Related]
6. Carbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography.
Dollé F
J Labelled Comp Radiopharm; 2013; 56(3-4):65-7. PubMed ID: 24285311
[TBL] [Abstract][Full Text] [Related]
7. Synthetic methodologies and PET imaging applications of fluorine-18 radiotracers: a patent review.
Nerella SG; Bhattacharya A; Thacker PS; Tulja S
Expert Opin Ther Pat; 2022 Apr; 32(4):455-473. PubMed ID: 35072592
[TBL] [Abstract][Full Text] [Related]
8. Strategies for designing novel positron emission tomography (PET) radiotracers to cross the blood-brain barrier.
Lindberg A; Chassé M; Varlow C; Pees A; Vasdev N
J Labelled Comp Radiopharm; 2023 Jul; 66(9):205-221. PubMed ID: 36815704
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of [
Arisawa T; Kimura K; Miyazaki T; Takada Y; Nakajima W; Ota W; Ichijo S; Sano A; Hirao Y; Kurita JI; Nishimura Y; Takahashi T
Nucl Med Biol; 2022; 110-111():47-58. PubMed ID: 35642985
[TBL] [Abstract][Full Text] [Related]
10. Radiosynthesis and
Bdair H; Singleton TA; Ross K; Jolly D; Kang MS; Aliaga A; Tuznik M; Kaur T; Yous S; Soucy JP; Massarweh G; Scott PJH; Koeppe R; Spadoni G; Bedini A; Rudko DA; Gobbi G; Benkelfat C; Rosa-Neto P; Brooks AF; Kostikov A
ACS Chem Neurosci; 2022 May; 13(9):1382-1394. PubMed ID: 35420022
[TBL] [Abstract][Full Text] [Related]
11. New-generation radiotracers for nAChR and NET.
Ding YS; Fowler J
Nucl Med Biol; 2005 Oct; 32(7):707-18. PubMed ID: 16243646
[TBL] [Abstract][Full Text] [Related]
12.
Hu F; Morris PJ; Bonaventura J; Fan H; Mathews WB; Holt DP; Lam S; Boehm M; Dannals RF; Pomper MG; Michaelides M; Horti AG
Eur J Med Chem; 2021 Mar; 213():113047. PubMed ID: 33280897
[TBL] [Abstract][Full Text] [Related]
13. Fluorine-18-Labeled PET Radiotracers for Imaging Tryptophan Uptake and Metabolism: a Systematic Review.
John F; Muzik O; Mittal S; Juhász C
Mol Imaging Biol; 2020 Aug; 22(4):805-819. PubMed ID: 31512038
[TBL] [Abstract][Full Text] [Related]
14. Development of
Lai TH; Schröder S; Toussaint M; Dukić-Stefanović S; Kranz M; Ludwig FA; Fischer S; Steinbach J; Deuther-Conrad W; Brust P; Moldovan RP
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669003
[TBL] [Abstract][Full Text] [Related]
15. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography (PET) imaging with (18)F-based radiotracers.
Alauddin MM
Am J Nucl Med Mol Imaging; 2012; 2(1):55-76. PubMed ID: 23133802
[TBL] [Abstract][Full Text] [Related]
17. Development of indazolylpyrimidine derivatives as high-affine EphB4 receptor ligands and potential PET radiotracers.
Ebert K; Wiemer J; Caballero J; Köckerling M; Steinbach J; Pietzsch J; Mamat C
Bioorg Med Chem; 2015 Sep; 23(17):6025-35. PubMed ID: 26189032
[TBL] [Abstract][Full Text] [Related]
18. PET radiotracers: crossing the blood-brain barrier and surviving metabolism.
Pike VW
Trends Pharmacol Sci; 2009 Aug; 30(8):431-40. PubMed ID: 19616318
[TBL] [Abstract][Full Text] [Related]
19. PET radiotracer development for imaging high-affinity state of dopamine D2 and D3 receptors: Binding studies of fluorine-18 labeled aminotetralins in rodents.
Mukherjee J; Majji D; Kaur J; Constantinescu CC; Narayanan TK; Shi B; Nour MT; Pan ML
Synapse; 2017 Mar; 71(3):. PubMed ID: 27864853
[TBL] [Abstract][Full Text] [Related]
20. Fluorine-18 radiolabeling and radiopharmacological characterization of a benzodioxolylpyrimidine-based radiotracer targeting the receptor tyrosine kinase EphB4.
Mamat C; Mosch B; Neuber C; Köckerling M; Bergmann R; Pietzsch J
ChemMedChem; 2012 Nov; 7(11):1991-2003. PubMed ID: 23042640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
